Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU
Copyright © 2023 Massachusetts Medical Society..
BACKGROUND: Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition and in insulin-induced severe hypoglycemia might explain this inconsistency.
METHODS: We randomly assigned patients, on ICU admission, to liberal glucose control (insulin initiated only when the blood-glucose level was >215 mg per deciliter [>11.9 mmol per liter]) or to tight glucose control (blood-glucose level targeted with the use of the LOGIC-Insulin algorithm at 80 to 110 mg per deciliter [4.4 to 6.1 mmol per liter]); parenteral nutrition was withheld in both groups for 1 week. Protocol adherence was determined according to glucose metrics. The primary outcome was the length of time that ICU care was needed, calculated on the basis of time to discharge alive from the ICU, with death accounted for as a competing risk; 90-day mortality was the safety outcome.
RESULTS: Of 9230 patients who underwent randomization, 4622 were assigned to liberal glucose control and 4608 to tight glucose control. The median morning blood-glucose level was 140 mg per deciliter (interquartile range, 122 to 161) with liberal glucose control and 107 mg per deciliter (interquartile range, 98 to 117) with tight glucose control. Severe hypoglycemia occurred in 31 patients (0.7%) in the liberal-control group and 47 patients (1.0%) in the tight-control group. The length of time that ICU care was needed was similar in the two groups (hazard ratio for earlier discharge alive with tight glucose control, 1.00; 95% confidence interval, 0.96 to 1.04; P = 0.94). Mortality at 90 days was also similar (10.1% with liberal glucose control and 10.5% with tight glucose control, P = 0.51). Analyses of eight prespecified secondary outcomes suggested that the incidence of new infections, the duration of respiratory and hemodynamic support, the time to discharge alive from the hospital, and mortality in the ICU and hospital were similar in the two groups, whereas severe acute kidney injury and cholestatic liver dysfunction appeared less prevalent with tight glucose control.
CONCLUSIONS: In critically ill patients who were not receiving early parenteral nutrition, tight glucose control did not affect the length of time that ICU care was needed or mortality. (Funded by the Research Foundation-Flanders and others; TGC-Fast ClinicalTrials.gov number, NCT03665207.).
Errataetall: |
CommentIn: N Engl J Med. 2023 Dec 7;389(23):2206. - PMID 38055261 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:389 |
---|---|
Enthalten in: |
The New England journal of medicine - 389(2023), 13 vom: 28. Sept., Seite 1180-1190 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gunst, Jan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Blood Glucose |
---|
Anmerkungen: |
Date Completed 28.09.2023 Date Revised 21.02.2024 published: Print ClinicalTrials.gov: NCT03665207 CommentIn: N Engl J Med. 2023 Dec 7;389(23):2206. - PMID 38055261 Citation Status MEDLINE |
---|
doi: |
10.1056/NEJMoa2304855 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362506086 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362506086 | ||
003 | DE-627 | ||
005 | 20240222232034.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1056/NEJMoa2304855 |2 doi | |
028 | 5 | 2 | |a pubmed24n1302.xml |
035 | |a (DE-627)NLM362506086 | ||
035 | |a (NLM)37754283 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gunst, Jan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2023 | ||
500 | |a Date Revised 21.02.2024 | ||
500 | |a published: Print | ||
500 | |a ClinicalTrials.gov: NCT03665207 | ||
500 | |a CommentIn: N Engl J Med. 2023 Dec 7;389(23):2206. - PMID 38055261 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Massachusetts Medical Society. | ||
520 | |a BACKGROUND: Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition and in insulin-induced severe hypoglycemia might explain this inconsistency | ||
520 | |a METHODS: We randomly assigned patients, on ICU admission, to liberal glucose control (insulin initiated only when the blood-glucose level was >215 mg per deciliter [>11.9 mmol per liter]) or to tight glucose control (blood-glucose level targeted with the use of the LOGIC-Insulin algorithm at 80 to 110 mg per deciliter [4.4 to 6.1 mmol per liter]); parenteral nutrition was withheld in both groups for 1 week. Protocol adherence was determined according to glucose metrics. The primary outcome was the length of time that ICU care was needed, calculated on the basis of time to discharge alive from the ICU, with death accounted for as a competing risk; 90-day mortality was the safety outcome | ||
520 | |a RESULTS: Of 9230 patients who underwent randomization, 4622 were assigned to liberal glucose control and 4608 to tight glucose control. The median morning blood-glucose level was 140 mg per deciliter (interquartile range, 122 to 161) with liberal glucose control and 107 mg per deciliter (interquartile range, 98 to 117) with tight glucose control. Severe hypoglycemia occurred in 31 patients (0.7%) in the liberal-control group and 47 patients (1.0%) in the tight-control group. The length of time that ICU care was needed was similar in the two groups (hazard ratio for earlier discharge alive with tight glucose control, 1.00; 95% confidence interval, 0.96 to 1.04; P = 0.94). Mortality at 90 days was also similar (10.1% with liberal glucose control and 10.5% with tight glucose control, P = 0.51). Analyses of eight prespecified secondary outcomes suggested that the incidence of new infections, the duration of respiratory and hemodynamic support, the time to discharge alive from the hospital, and mortality in the ICU and hospital were similar in the two groups, whereas severe acute kidney injury and cholestatic liver dysfunction appeared less prevalent with tight glucose control | ||
520 | |a CONCLUSIONS: In critically ill patients who were not receiving early parenteral nutrition, tight glucose control did not affect the length of time that ICU care was needed or mortality. (Funded by the Research Foundation-Flanders and others; TGC-Fast ClinicalTrials.gov number, NCT03665207.) | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
700 | 1 | |a Debaveye, Yves |e verfasserin |4 aut | |
700 | 1 | |a Güiza, Fabian |e verfasserin |4 aut | |
700 | 1 | |a Dubois, Jasperina |e verfasserin |4 aut | |
700 | 1 | |a De Bruyn, Astrid |e verfasserin |4 aut | |
700 | 1 | |a Dauwe, Dieter |e verfasserin |4 aut | |
700 | 1 | |a De Troy, Erwin |e verfasserin |4 aut | |
700 | 1 | |a Casaer, Michael P |e verfasserin |4 aut | |
700 | 1 | |a De Vlieger, Greet |e verfasserin |4 aut | |
700 | 1 | |a Haghedooren, Renata |e verfasserin |4 aut | |
700 | 1 | |a Jacobs, Bart |e verfasserin |4 aut | |
700 | 1 | |a Meyfroidt, Geert |e verfasserin |4 aut | |
700 | 1 | |a Ingels, Catherine |e verfasserin |4 aut | |
700 | 1 | |a Muller, Jan |e verfasserin |4 aut | |
700 | 1 | |a Vlasselaers, Dirk |e verfasserin |4 aut | |
700 | 1 | |a Desmet, Lars |e verfasserin |4 aut | |
700 | 1 | |a Mebis, Liese |e verfasserin |4 aut | |
700 | 1 | |a Wouters, Pieter J |e verfasserin |4 aut | |
700 | 1 | |a Stessel, Björn |e verfasserin |4 aut | |
700 | 1 | |a Geebelen, Laurien |e verfasserin |4 aut | |
700 | 1 | |a Vandenbrande, Jeroen |e verfasserin |4 aut | |
700 | 1 | |a Brands, Michiel |e verfasserin |4 aut | |
700 | 1 | |a Gruyters, Ine |e verfasserin |4 aut | |
700 | 1 | |a Geerts, Ester |e verfasserin |4 aut | |
700 | 1 | |a De Pauw, Ilse |e verfasserin |4 aut | |
700 | 1 | |a Vermassen, Joris |e verfasserin |4 aut | |
700 | 1 | |a Peperstraete, Harlinde |e verfasserin |4 aut | |
700 | 1 | |a Hoste, Eric |e verfasserin |4 aut | |
700 | 1 | |a De Waele, Jan J |e verfasserin |4 aut | |
700 | 1 | |a Herck, Ingrid |e verfasserin |4 aut | |
700 | 1 | |a Depuydt, Pieter |e verfasserin |4 aut | |
700 | 1 | |a Wilmer, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Hermans, Greet |e verfasserin |4 aut | |
700 | 1 | |a Benoit, Dominique D |e verfasserin |4 aut | |
700 | 1 | |a Van den Berghe, Greet |e verfasserin |4 aut | |
700 | 0 | |a TGC-Fast Collaborators |e verfasserin |4 aut | |
700 | 1 | |a Gunst, Jan |e investigator |4 oth | |
700 | 1 | |a Debaveye, Yves |e investigator |4 oth | |
700 | 1 | |a Güiza, Fabian |e investigator |4 oth | |
700 | 1 | |a Dubois, Jasperina |e investigator |4 oth | |
700 | 1 | |a De Bruyn, Astrid |e investigator |4 oth | |
700 | 1 | |a Dauwe, Dieter |e investigator |4 oth | |
700 | 1 | |a De Troy, Erwin |e investigator |4 oth | |
700 | 1 | |a Casaer, Michael P |e investigator |4 oth | |
700 | 1 | |a De Vlieger, Greet |e investigator |4 oth | |
700 | 1 | |a Haghedooren, Renata |e investigator |4 oth | |
700 | 1 | |a Jacobs, Bart |e investigator |4 oth | |
700 | 1 | |a Meyfroidt, Geert |e investigator |4 oth | |
700 | 1 | |a Ingels, Catherine |e investigator |4 oth | |
700 | 1 | |a Muller, Jan |e investigator |4 oth | |
700 | 1 | |a Vlasselaers, Dirk |e investigator |4 oth | |
700 | 1 | |a Desmet, Lars |e investigator |4 oth | |
700 | 1 | |a Mebis, Liese |e investigator |4 oth | |
700 | 1 | |a Wouters, Pieter J |e investigator |4 oth | |
700 | 1 | |a Stessel, Björn |e investigator |4 oth | |
700 | 1 | |a Geebelen, Laurien |e investigator |4 oth | |
700 | 1 | |a Vandenbrande, Jeroen |e investigator |4 oth | |
700 | 1 | |a Brands, Michiel |e investigator |4 oth | |
700 | 1 | |a Gruyters, Ine |e investigator |4 oth | |
700 | 1 | |a Geerts, Ester |e investigator |4 oth | |
700 | 1 | |a De Pauw, Ilse |e investigator |4 oth | |
700 | 1 | |a Vermassen, Joris |e investigator |4 oth | |
700 | 1 | |a Peperstraete, Harlinde |e investigator |4 oth | |
700 | 1 | |a Hoste, Eric |e investigator |4 oth | |
700 | 1 | |a De Waele, Jan J |e investigator |4 oth | |
700 | 1 | |a Herck, Ingrid |e investigator |4 oth | |
700 | 1 | |a Depuydt, Pieter |e investigator |4 oth | |
700 | 1 | |a Wilmer, Alexander |e investigator |4 oth | |
700 | 1 | |a Hermans, Greet |e investigator |4 oth | |
700 | 1 | |a Benoit, Dominique D |e investigator |4 oth | |
700 | 1 | |a Van den Berghe, Greet |e investigator |4 oth | |
700 | 1 | |a Huynen, Philippe |e investigator |4 oth | |
700 | 1 | |a Coucke, Colin |e investigator |4 oth | |
700 | 1 | |a Dehouwer, Alexander |e investigator |4 oth | |
700 | 1 | |a De Ridder, Simon |e investigator |4 oth | |
700 | 1 | |a Dekeyser, Melanie |e investigator |4 oth | |
700 | 1 | |a Dionys, Annelies |e investigator |4 oth | |
700 | 1 | |a Hendrickx, Maarten |e investigator |4 oth | |
700 | 1 | |a Maeckelberghe, Mieke |e investigator |4 oth | |
700 | 1 | |a Schildermans, Jolien |e investigator |4 oth | |
700 | 1 | |a Staelens, Walter |e investigator |4 oth | |
700 | 1 | |a Hendrickx, Alexandra |e investigator |4 oth | |
700 | 1 | |a Utens, Heidi |e investigator |4 oth | |
700 | 1 | |a Van Cleemput, Hanna |e investigator |4 oth | |
700 | 1 | |a Van Hulle, Sylvia |e investigator |4 oth | |
700 | 1 | |a Witpas, Katleen |e investigator |4 oth | |
700 | 1 | |a Meersseman, Philippe |e investigator |4 oth | |
700 | 1 | |a Wauters, Joost |e investigator |4 oth | |
700 | 1 | |a Peetermans, Marijke |e investigator |4 oth | |
700 | 1 | |a Callebaut, Ina |e investigator |4 oth | |
700 | 1 | |a Coninckx, Greetje |e investigator |4 oth | |
700 | 1 | |a Jamaer, Philippe |e investigator |4 oth | |
700 | 1 | |a Nulens, Marijke |e investigator |4 oth | |
700 | 1 | |a Swinnen, Vital |e investigator |4 oth | |
700 | 1 | |a Herbots, Jeroen |e investigator |4 oth | |
700 | 1 | |a Heremans, Liesbeth |e investigator |4 oth | |
700 | 1 | |a Hermans, Johan |e investigator |4 oth | |
700 | 1 | |a Berends, Noor |e investigator |4 oth | |
700 | 1 | |a Van Tornout, Michiel |e investigator |4 oth | |
700 | 1 | |a Vranken, Dirk |e investigator |4 oth | |
700 | 1 | |a Jalil, Hassanin |e investigator |4 oth | |
700 | 1 | |a Fierens, Jan |e investigator |4 oth | |
700 | 1 | |a Druwé, Patrick |e investigator |4 oth | |
700 | 1 | |a Oeyen, Sandra |e investigator |4 oth | |
700 | 1 | |a De Bus, Liesbet |e investigator |4 oth | |
700 | 1 | |a Colpaert, Kirsten |e investigator |4 oth | |
700 | 1 | |a Vanhulle, Lander |e investigator |4 oth | |
700 | 1 | |a Roosens, Carl |e investigator |4 oth | |
700 | 1 | |a Decruyenaere, Johan |e investigator |4 oth | |
700 | 1 | |a Vanderbiest, Klaas |e investigator |4 oth | |
700 | 1 | |a Vandenberghe, Wim |e investigator |4 oth | |
700 | 1 | |a Van Laethem, Lien |e investigator |4 oth | |
700 | 1 | |a Schaubroeck, Hannah |e investigator |4 oth | |
700 | 1 | |a Dillemans, Julie |e investigator |4 oth | |
700 | 1 | |a Couck, Thomas |e investigator |4 oth | |
700 | 1 | |a Vermeiren, Daisy |e investigator |4 oth | |
700 | 1 | |a Van Hecke, Jolien |e investigator |4 oth | |
700 | 1 | |a De Smeytere, Anouska |e investigator |4 oth | |
700 | 1 | |a Decoster, Lesley |e investigator |4 oth | |
700 | 1 | |a Gadeyne, Bram |e investigator |4 oth | |
700 | 1 | |a Brams, Veerle |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 389(2023), 13 vom: 28. Sept., Seite 1180-1190 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
773 | 1 | 8 | |g volume:389 |g year:2023 |g number:13 |g day:28 |g month:09 |g pages:1180-1190 |
856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMoa2304855 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 389 |j 2023 |e 13 |b 28 |c 09 |h 1180-1190 |